DOST: Initial data analysis results on VCO, lagundi as COVID-19 therapeutic expected by July

Published June 27, 2021, 2:37 PM
The “preliminary” results of the clinical trials on the use of the Virgin Coconut Oil (VCO), and lagundi (Chinese chaste tree) as a coronavirus disease (COVID-19) therapeutic or supplement could be expected by next month, an official of the Philippine Council for Health Research and Development (PCHRD) of the Department of Science and Technology (DOST-PCHRD) said on Sunday, June 27.
Virgin coconut oil (upper photo), Tawa-tawa (lower left), Lagundi (lower right) (MANILA BULLETIN FILE PHOTOS)
DOST-PCHRD Executive Director Dr. Jaime C. Montoya said the VCO clinical trial at the Philippine General Hospital (PGH) will be completed by end of this month and the initial analysis of the data is expected to be conducted, while the project team handling the lagundi clinical trials is currently conducting their data analysis.

Related Keywords

China ,Ottawa ,Palawan ,Philippines ,Manila ,Philippine ,Benguet ,Lagundi ,Camarines Norte ,Visayas ,Philippines General ,Chinese ,Jaimec Montoya ,Philip Ian Padilla ,Philippine Council For Health Research ,Department Of Science ,Virgin Coconut Oil ,Philippine Council ,Health Research ,Philippine General Hospital ,சீனா ,தவா ,பலவன் ,பிலிப்பைன்ஸ் ,மணிலா ,பிலிப்பைன் ,விசயாஸ் ,சீன ,பிலிப்பைன் சபை க்கு ஆரோக்கியம் ஆராய்ச்சி ,துறை ஆஃப் அறிவியல் ,கன்னி தேங்காய் எண்ணெய் ,பிலிப்பைன் சபை ,ஆரோக்கியம் ஆராய்ச்சி ,பிலிப்பைன் ஜநரல் மருத்துவமனை ,